Claire Parker
NURSE PRACTITIONER 3
COO Children Services
Chancellor/EVC/FAS

Publications (14)

Top publication keywords:
PouchitisBiological ProductsSpondylitis, AnkylosingAntibody FormationInterleukin-23 Subunit p19Crohn DiseaseJanus Kinase InhibitorsPsoriasisInterleukin-23Disease ProgressionRemission InductionArthritis, RheumatoidInflammatory Bowel DiseasesColitis, UlcerativeBone Morphogenetic Protein Receptors, Type II

• Systematic review: Defining, diagnosing and monitoring small bowel strictures in Crohn's disease on intestinal ultrasound.
  Alimentary pharmacology & therapeutics 2024 Lu C, Rosentreter R, Delisle M, White M, Parker CE, Premji Z, Wilson SR, Baker ME, Bhatnagar G, Begun J, Bruining DH, Bryant R, Christensen B, Feagan BG, Fletcher JG, Jairath V, Knudsen J, Kucharzik T…
• Use of external control arms in immune-mediated inflammatory diseases: a systematic review.
  BMJ open 2023 Zayadi A, Edge R, Parker CE, Macdonald JK, Neustifter B, Chang J, Zhong G, Singh S, Feagan BG, Ma C, Jairath V
• Reliability and Responsiveness of Histologic Indices for the Assessment of Crohn's Disease Activity.
  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2023 Solitano V, Schaeffer DF, Hogan M, Vande Casteele N, Pai RK, Zou G, Pai RK, Parker CE, Rémillard J, Christensen B, Danese S, Peyrin-Biroulet L, Panaccione R, Sands BE, D'Haens G, Feagan BG, Ma C, …
• Efficacy and Safety of Advanced Oral Small Molecules for Inflammatory Bowel Disease: Systematic Review and Meta-Analysis.
  Journal of Crohn's & colitis 2023 Solitano V, Vuyyuru SK, MacDonald JK, Zayadi A, Parker CE, Narula N, Peyrin-Biroulet L, Danese S, Feagan BG, Singh S, Ma C, Jairath V
• Safety and tolerability of continuous inhaled iloprost in critically ill pediatric pulmonary hypertension patients: A retrospective case series.
  Pulmonary circulation 2023 Colglazier E, Ng AJ, Parker C, Woolsey D, Holmes R, Dsouza A, Becerra J, Stevens L, Nawaytou H, Keller RL, Fineman JR

Show all (9 more) Hide

• Efficacy and Safety of IL-12/23 and IL-23 Inhibitors for Crohn's Disease: Systematic Review and Meta-Analysis.
  Digestive diseases and sciences 2023 Vuyyuru SK, Solitano V, Hogan M, MacDonald JK, Zayadi A, Parker CE, Sands BE, Panaccione R, Narula N, Feagan BG, Singh S, Jairath V, Ma C
• Hemodynamic assessment of transitioning from parenteral prostacyclin to selexipag in pediatric pulmonary hypertension.
  Pulmonary circulation 2022 Colglazier E, Stevens L, Parker C, Nawaytou HM, Amin EK, Becerra J, Steurer M, Fineman JR
• CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease.
  Gastroenterology 2022 CORE-IBD Collaborators, Ma C, Hanzel J, Panaccione R, Sandborn WJ, D'Haens GR, Ahuja V, Atreya R, Bernstein CN, Bossuyt P, Bressler B, Bryant RV, Cohen B, Colombel JF, Danese S, Dignass A, Dubinsky MC…
• Caveolin-1 associated with severe (pediatric-onset) presentation of pulmonary arterial hypertension.
  Pulmonary circulation 2022 Farrell R, Colglazier E, Parker C, Stevens L, Austin ED, Fineman JR
• Persistence of persistent pulmonary hypertension of the newborn: A case of de novo TBX4 variant.
  Pulmonary circulation 2022 Tsoi SM, Jones K, Colglazier E, Parker C, Nawaytou H, Teitel D, Fineman JR, Keller RL
• Clinical, Endoscopic, and Safety Placebo Rates in Induction and Maintenance Trials of Crohn's Disease: Meta-Analysis of Randomised Controlled Trials.
  Journal of Crohn's & colitis 2022 Almradi A, Sedano R, Hogan M, Zou GY, MacDonald JK, Parker CE, Hanzel J, Crowley E, Singh S, D'Haens G, Sandborn WJ, Feagan BG, Ma C, Jairath V
• Genetics dictating therapeutic decisions in pediatric pulmonary hypertension? A case report suggesting we are getting closer.
  Pulmonary circulation 2022 Stevens L, Colglazier E, Parker C, Amin EK, Nawaytou H, Teitel D, Reddy VM, Welch CL, Chung WK, Fineman JR
• Anti-Drug Antibody Formation Against Biologic Agents in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
  BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 2021 Bots SJ, Parker CE, Brandse JF, Löwenberg M, Feagan BG, Sandborn WJ, Jairath V, D'Haens G, Vande Casteele N
• Novel Documentation of Onset and Rapid Advancement of Pulmonary Arterial Hypertension without Symptoms in BMPR2 Mutation Carriers: Cautionary Tales?
  American journal of respiratory and critical care medicine 2020 Amin EK, Austin ED, Parker C, Colglazier E, Nawaytou H, Leary PJ, Hemnes AR, Teitel D, Fineman JR